Drug Type Small molecule drug |
Synonyms Ferrous succinate |
Target- |
Mechanism Fe modulators |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization- |
Inactive Organization- |
Drug Highest PhaseApproved |
First Approval Date- |
Regulation- |
Molecular FormulaC4H6FeO4 |
InChIKeyVAMMNAAZSNNEDJ-UHFFFAOYSA-N |
CAS Registry10030-90-7 |
Indication | Country/Location | Organization | Date |
---|---|---|---|
Anemia, Iron-Deficiency | CN | 01 Jan 1993 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Cognitive Dysfunction | Phase 2 | CN | 24 May 2024 | |
Cognitive Dysfunction | Phase 2 | - | 24 May 2024 | |
Ischemic Attack, Transient | Phase 2 | CN | 24 May 2024 | |
Ischemic Attack, Transient | Phase 2 | - | 24 May 2024 | |
Stroke | Phase 2 | CN | 24 May 2024 | |
Stroke | Phase 2 | - | 24 May 2024 |